Journal article
The sleep, cancer and rest (SleepCaRe) trial: Rationale and design of a randomized, controlled trial of cognitive behavioral and bright light therapy for insomnia and fatigue in women with breast cancer receiving chemotherapy
J Maccora, SN Garland, M Ftanou, D Day, M White, VA Lopez, D Mortimer, J Diggens, AJK Phillips, R Wallace, M Alexander, F Boyle, L Stafford, PA Francis, B Bei, JF Wiley
Contemporary Clinical Trials | Published : 2022
Abstract
Background: Insomnia and fatigue symptoms are common in breast cancer. Active cancer treatment, such as chemotherapy, appears to be particularly disruptive to sleep. Yet, sleep complaints often go unrecognised and under treated within routine cancer care. The abbreviated delivery of cognitive behavioral therapy for Insomnia (CBT–I) and bright light therapy (BLT) may offer accessible and cost-effective sleep treatments in women receiving chemotherapy for breast cancer. Methods: The Sleep, Cancer and Rest (SleepCaRe) Trial is a 6-month multicentre, randomized, controlled, 2 × 2 factorial, superiority, parallel group trial. Women receiving cytotoxic chemotherapy for breast cancer at tertiary Au..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This work was supported by seed funding from Monash University with light glasses provided by Lucimed SA, Belgium. Wiley (1178487) and Bei (1140299) were supported by NHMRC fellowships. The funders had no role in the study design, data collection, analysis, interpretation, or presentation of results.